monoclonal antibodies (mAbs). Chromatography is based on different interactions
between the target viral particle and components placed on the stationary phase.
These interactions rely on the surface properties of the viral particle (adsorptive
chromatography) or their size (size exclusion chromatography). In the case of ad-
sorptive chromatography, the viral particles’ solution is passed through a solid
phase (stationary phase) coated with functional groups that capture the viral particle
(also known as bind-and-elude mode or positive chromatography) or capture the
impurities (also known as flow-through mode or negative chromatography). This
depends on the global charge of the virus and the operation mode. In this case,
cationic or anionic exchangers can be used. Ion exchange chromatography (IEX) is
the most used chromatographic technique in vaccines and viral vectors manu-
facturing, exploring the reversible interaction between a charged particle surface
and an oppositely charged matrix. Besides IEX, there are other interactions which
have been exploited such as affinity (AC), hydrophobic interaction (HIC), mixed-
mode (MMC), and size exclusion (SEC). Affinity chromatography, used for long
time in protein purification, has recently gained special prominence in the complex
biotherapeutics field due to their specificity separation, high degree of purity
and recovery, and consequent contribution to the reduction of necessary unit op-
erations [52,53].
The flow-through mode chromatography avoids some of the issues addressed
with other chromatography separation methods, being transversal for different
biological systems. Harsh elution conditions may be omitted and, consequently, the
risk of immunogenicity/infectivity loss and aggregation is also reduced [54]. This
strategy has been recently evaluated for the purification of hepatitis C virus-like
particles. In this process, the product is recovered in the flow-through, avoiding
harsh elution conditions and the risk of virus’s disassembly [37].
The stationary phase can be physically structured as packed beds, membrane
adsorbers, and monoliths, as shown in Figure 7.5. The most commonly used are
packed beds, which consist of beads physically packed into a chromatographic
column. They were extensively used for protein separation, but viruses are gen-
erally larger than proteins, between 20 nm to 400 nm, resulting in low binding
capacities [55]. Given the high interest in developing purification processes for viral
particles, there are already some novel optimized resins suitable for the purification
of large molecules such as POROS® (ThermoFisher Scientific) and NUVIA HP-Q®
(Bio-Rad). These beads are especially suitable for large molecules, due to their
rigidity, robustness, and increased surface area. However, these resins largely de-
pend on the size of the target molecule, especially in the case of a virus. They might
be ideal for small viruses (20–30 nm) such as AAV or poliovirus but they show
limitations for larger viruses (above 80–100 nm), which is the case for the majority
of oncolytic viruses.
Chromatography on convective flow devices such as monoliths, nanofibers, and
membrane adsorbers has been emerging as an efficient alternative to conventional
ones. As depicted in Table 7.2, membrane chromatography has several advantages
over packed-bed chromatography. Owing to their different architecture, mass
transport through the pores/channels takes place mainly by convection overcoming
virus particle diffusion issues faced by the traditional packed-bed chromatography.
186
Bioprocessing of Viral Vaccines